1,4-dihydropyridine has been researched along with Kidney Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Donaire, JA; Ruilope, LM; Segura, J | 1 |
| Ferentinou, E; Kaperonis, N; Karakasis, F; Kourvelou, C; Ntatsis, G; Papagalanis, N; Ziakka, S | 1 |
| Abe, K; Imai, Y; Saito, T; Saruta, T; Suzuki, H; Tsuji, I | 1 |
1 review(s) available for 1,4-dihydropyridine and Kidney Diseases
| Article | Year |
|---|---|
Are differences in calcium antagonists relevant across all stages of nephropathy or only proteinuric nephropathy?
Topics: Albuminuria; Angiotensins; Animals; Antihypertensive Agents; Blood Pressure; Calcium; Calcium Channel Blockers; Clinical Trials as Topic; Dihydropyridines; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Proteinuria | 2007 |
1 trial(s) available for 1,4-dihydropyridine and Kidney Diseases
| Article | Year |
|---|---|
The effect of pravastatin on renal function and lipid metabolism in patients with renal dysfunction with hypertension and hyperlipidemia. Pravastatin and Renal Function Research Group.
Topics: Blood Urea Nitrogen; Calcium Channel Blockers; Cholesterol; Creatinine; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Kidney Diseases; Male; Middle Aged; Pravastatin; Treatment Outcome | 1999 |
1 other study(ies) available for 1,4-dihydropyridine and Kidney Diseases
| Article | Year |
|---|---|
Calcium channels blockers and progression of kidney disease.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Disease Progression; Female; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Proteinuria | 2007 |